지난 3일 식품의약품안전처가 의약품 성분이 뒤바뀐 인보사 품목허가 취소 처분을 확정한데 따른 입장 발표다.
On the 3rd, the Ministry of Food and Drug Safety announced its position as it confirmed the cancellation of Invossa's item permission, in which the drug ingredients were changed.